drugset / Trial / NCT00168571

Summary

Few data exist on long-term persistence of measles antibodies after vaccination of West African infants. The data that do exist indicate that the antibody titres decline very rapidly. Our data would be the first to describe the persistence of measles antibodies after two doses of measles vaccine, and the study would allow us to identify unprotected children and offer them revaccination. Since persistence of measles antibodies is of crucial importance to measles control, the study will contribute significantly to the existing knowledge and might have important implications for future eradication programmes.

Timeline

Start
2002-03
Primary completion
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Measles vaccine Vaccine

Indications